Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: A cross-sectional survey

Diabetic Medicine

Volumn 23, Issue 7, 2006, Pages 750-756

  Akram, K ^a   Pedersen Bjergaard, U ^b   Carstensen, B ^a   Borch Johnsen, K ^a   Thorsteinsson, B ^b  

^a STENO DIABETES CENTER   (Denmark)

^b HILLERØD HOSPITAL   (Denmark)

Author keywords

Hypoglycaemia; Hypoglycaemia awareness; Insulin therapy; Risk factors; Type 2 diabetes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; QUESTIONNAIRE; RISK FACTOR; SOCIAL ASPECT;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATTITUDE TO HEALTH; C-PEPTIDE; CROSS-SECTIONAL STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; RECEPTORS, ANGIOTENSIN; RISK FACTORS;

EID: 33748578996     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01880.x     Document Type: Article

References (27)

1. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
2. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
3. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J et al. European guidelines on cardiovascular disease prevention in clinical practice. Atherosclerosis 2003; 170: 145-155.
4. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
5. Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 1995; 130: 389-396.
6. Hepburn DA, MacLeod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with Type 2 diabetes treated with insulin. Diabet Med 1993; 10: 231-237.
7. MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med 1993; 10: 238-245.
8. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001; 161: 1653-1659.
9. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med 2003; 20: 1016-1021.
10. Pedersen-Bjergaard U, Pramming S, Heller SR, Wallace TM, Rasmussen AK, Jorgensen HV et al. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 2004; 20: 479-486.
11. Pedersen-Bjergaard U, Pramming S, Thorsteinsson B. Recall of severe hypoglycaemia and self-estimated state of awareness in type 1 diabetes. Diabetes Metab Res Rev 2003; 19: 232-240.
12. Akram K, Pedersen-Bjergaard U, Borch-Johnsen K, Thorsteinsson B. Recall of severe hypoglycaemic episodes and course of hypoglycaemia awareness in insulin-treated type 2 diabetes in one year follow-up. Diabetologia 2003; 46: A304.
13. Bulsara MK, Holman CD, Davis EA, Jones TW. Evaluating risk factors associated with severe hypoglycaemia in epidemiology studies - what method should we use? Diabet Med 2004; 21: 914-919.
14. Larsen K, Petersen JH, Budtz-Jørgensen E, Endahl L. Interpreting parameters in the logistic regression model with random effects. Biometrics 2000; 56: 909-914.
15. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R et al. Frequency and predictors of hypoglycemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755.
16. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003; 26: 1176-1180.
17. Muhlhauser I, Overmann H, Bender R, Bott U, Berger M. Risk factors of severe hypoglycaemia in adult patients with Type I diabetes - a prospective population-based study. Diabetologia 1998; 41: 1274-1282.
18. The Diabetes Control and Complications Trial (DCCT) Research Group. Hypoglycaemia in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 271-286.
19. Segel SA, Paramore DS, Cryer PE. Hypoglycaemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51: 724-733.
20. ter Braak EW, Appelman AM, van de Laak M, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycaemia. Diabetes Care 2000; 23: 1467-147.
21. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Activity of angiotensin-converting enzyme and risk of severe hypoglycaemia in type 1 diabetes mellitus. Lancet 2001; 357: 1248-1253.
22. Pedersen-Bjergaard U, Agerholm-Larsen B, Pramming S, Hougaard P, Thorsteinsson B. Prediction of severe hypoglycaemia by angiotensin-converting enzyme activity and genotype in type 1 diabetes. Diabetologia 2003; 46: 89-96.
23. Nordfeldt S, Samuelsson U. Serum ACE predicts severe hypoglycaemia in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 274-278.
24. Morris AD, Boyle DI, McMahon AD, Pearce H, Evans JM, Newton RW et al. ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care 1997; 20: 1363-1367.
25. The EUCLID Study Group. Randomised placebo-controlled trial of Lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. Lancet 1997; 349: 1787-1792.
26. Pedersen-Bjergaard U, Smed A, Thomsen C, Høgenhaven H, Holst JJ, Frandsen E et al. The impact of ACE activity on cognitive function, symptoms of hypoglycaemia and hormonal counterregulation during hypoglycaemia in normal subjects. Diabetes 2003; 52: A30.
27. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The impact of severe hypoglycaemia and impaired awareness of hypoglycaemia on relatives of patients with type 1 diabetes. Diabetes Care 2003; 26: 1106-1109.